Noel Mueller
 
																	
																		 Concepts  (500)
																	
																		
																	 
																	
																		Concepts are derived automatically from a person's publications.  
																	
																	
																			
																					
    Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
     | Name | 
              Number of Publications
             | 
              Most Recent Publication
             | 
              Publications by All Authors
             | 
              Concept Score
             | 
              Why?
             | 
|---|
 | Gastrointestinal Microbiome | 26  | 2025  | 696  | 8.850  | 
                  Why?
                 |  | Cesarean Section | 14  | 2025  | 187  | 5.110  | 
                  Why?
                 |  | Microbiota | 15  | 2024  | 763  | 4.940  | 
                  Why?
                 |  | Delivery, Obstetric | 10  | 2022  | 147  | 3.990  | 
                  Why?
                 |  | Fatty Acids, Volatile | 8  | 2025  | 58  | 3.420  | 
                  Why?
                 |  | Pre-Eclampsia | 7  | 2025  | 191  | 3.190  | 
                  Why?
                 |  | Adiposity | 11  | 2024  | 517  | 2.910  | 
                  Why?
                 |  | Pediatric Obesity | 13  | 2025  | 592  | 2.730  | 
                  Why?
                 |  | Trace Elements | 4  | 2021  | 52  | 2.700  | 
                  Why?
                 |  | Body Mass Index | 30  | 2025  | 2369  | 2.580  | 
                  Why?
                 |  | Menarche | 7  | 2023  | 60  | 2.510  | 
                  Why?
                 |  | Hypertension | 12  | 2025  | 1293  | 2.360  | 
                  Why?
                 |  | Blood Pressure | 17  | 2025  | 1776  | 2.260  | 
                  Why?
                 |  | Pregnancy | 42  | 2025  | 6745  | 2.210  | 
                  Why?
                 |  | Feces | 11  | 2024  | 479  | 2.110  | 
                  Why?
                 |  | Metals, Heavy | 3  | 2021  | 32  | 2.020  | 
                  Why?
                 |  | Prenatal Exposure Delayed Effects | 10  | 2024  | 608  | 2.020  | 
                  Why?
                 |  | Mothers | 13  | 2023  | 752  | 1.790  | 
                  Why?
                 |  | Vagina | 7  | 2024  | 186  | 1.740  | 
                  Why?
                 |  | Dietary Approaches To Stop Hypertension | 4  | 2025  | 13  | 1.670  | 
                  Why?
                 |  | Diabetes Mellitus, Type 2 | 14  | 2025  | 2521  | 1.590  | 
                  Why?
                 |  | Female | 107  | 2025  | 73162  | 1.550  | 
                  Why?
                 |  | Dietary Fiber | 3  | 2023  | 53  | 1.500  | 
                  Why?
                 |  | Metformin | 5  | 2022  | 328  | 1.500  | 
                  Why?
                 |  | Infant, Newborn | 24  | 2025  | 6059  | 1.440  | 
                  Why?
                 |  | Breast Feeding | 4  | 2025  | 439  | 1.410  | 
                  Why?
                 |  | Humans | 140  | 2025  | 137514  | 1.380  | 
                  Why?
                 |  | Fetal Blood | 4  | 2022  | 327  | 1.370  | 
                  Why?
                 |  | Milk, Human | 2  | 2024  | 158  | 1.360  | 
                  Why?
                 |  | Carbonated Beverages | 3  | 2015  | 16  | 1.310  | 
                  Why?
                 |  | Infant | 28  | 2025  | 9467  | 1.280  | 
                  Why?
                 |  | Dietary Carbohydrates | 3  | 2021  | 153  | 1.270  | 
                  Why?
                 |  | Premature Birth | 2  | 2023  | 331  | 1.210  | 
                  Why?
                 |  | Dietary Proteins | 2  | 2020  | 135  | 1.190  | 
                  Why?
                 |  | Obesity | 15  | 2022  | 2974  | 1.120  | 
                  Why?
                 |  | Cardiovascular Diseases | 9  | 2022  | 2113  | 1.110  | 
                  Why?
                 |  | Longevity | 2  | 2019  | 165  | 1.100  | 
                  Why?
                 |  | Prospective Studies | 23  | 2025  | 7598  | 1.090  | 
                  Why?
                 |  | Methylamines | 2  | 2024  | 34  | 1.030  | 
                  Why?
                 |  | Diet | 15  | 2024  | 1273  | 1.020  | 
                  Why?
                 |  | Metabolome | 3  | 2024  | 350  | 1.010  | 
                  Why?
                 |  | Male | 76  | 2025  | 67718  | 0.990  | 
                  Why?
                 |  | Child | 36  | 2025  | 22037  | 0.990  | 
                  Why?
                 |  | Non-Nutritive Sweeteners | 2  | 2015  | 5  | 0.990  | 
                  Why?
                 |  | Adult | 58  | 2024  | 37821  | 0.980  | 
                  Why?
                 |  | Health Impact Assessment | 2  | 2022  | 10  | 0.930  | 
                  Why?
                 |  | Diet, Sodium-Restricted | 3  | 2025  | 36  | 0.900  | 
                  Why?
                 |  | Plasminogen Activator Inhibitor 1 | 1  | 2024  | 86  | 0.880  | 
                  Why?
                 |  | Selenium | 2  | 2021  | 39  | 0.870  | 
                  Why?
                 |  | Longitudinal Studies | 13  | 2024  | 2857  | 0.860  | 
                  Why?
                 |  | Anti-Bacterial Agents | 5  | 2020  | 1800  | 0.850  | 
                  Why?
                 |  | Insulin Resistance | 6  | 2022  | 1198  | 0.840  | 
                  Why?
                 |  | Leg | 2  | 2015  | 223  | 0.830  | 
                  Why?
                 |  | Sugars | 1  | 2023  | 41  | 0.830  | 
                  Why?
                 |  | Infant Nutritional Physiological Phenomena | 3  | 2020  | 144  | 0.830  | 
                  Why?
                 |  | Bacteria | 5  | 2023  | 858  | 0.830  | 
                  Why?
                 |  | Risk Factors | 34  | 2024  | 10356  | 0.830  | 
                  Why?
                 |  | Manganese | 2  | 2020  | 63  | 0.820  | 
                  Why?
                 |  | Air Pollution | 3  | 2022  | 315  | 0.820  | 
                  Why?
                 |  | Osteoporotic Fractures | 1  | 2023  | 61  | 0.790  | 
                  Why?
                 |  | Cross-Sectional Studies | 16  | 2025  | 5427  | 0.770  | 
                  Why?
                 |  | RNA, Ribosomal, 16S | 3  | 2024  | 544  | 0.770  | 
                  Why?
                 |  | Blood Pressure Determination | 3  | 2019  | 156  | 0.750  | 
                  Why?
                 |  | Body Composition | 3  | 2025  | 668  | 0.750  | 
                  Why?
                 |  | Diet, Mediterranean | 1  | 2022  | 30  | 0.740  | 
                  Why?
                 |  | Overweight | 10  | 2021  | 554  | 0.720  | 
                  Why?
                 |  | Chorioamnionitis | 1  | 2021  | 42  | 0.720  | 
                  Why?
                 |  | HTLV-I Infections | 10  | 2000  | 24  | 0.720  | 
                  Why?
                 |  | Child, Preschool | 17  | 2025  | 11097  | 0.710  | 
                  Why?
                 |  | Birth Weight | 7  | 2024  | 516  | 0.710  | 
                  Why?
                 |  | Hypotension | 1  | 2022  | 123  | 0.710  | 
                  Why?
                 |  | Sex Hormone-Binding Globulin | 1  | 2020  | 59  | 0.680  | 
                  Why?
                 |  | Fats, Unsaturated | 1  | 2020  | 1  | 0.670  | 
                  Why?
                 |  | Dietary Fats, Unsaturated | 1  | 2020  | 23  | 0.660  | 
                  Why?
                 |  | Weight Gain | 3  | 2018  | 518  | 0.650  | 
                  Why?
                 |  | Flatulence | 1  | 2019  | 2  | 0.640  | 
                  Why?
                 |  | Dyspepsia | 1  | 2019  | 10  | 0.640  | 
                  Why?
                 |  | Body Fluids | 1  | 2019  | 66  | 0.640  | 
                  Why?
                 |  | Androgens | 1  | 2020  | 188  | 0.610  | 
                  Why?
                 |  | Pressure | 1  | 2020  | 244  | 0.600  | 
                  Why?
                 |  | Cohort Studies | 14  | 2023  | 5730  | 0.600  | 
                  Why?
                 |  | Abdominal Pain | 1  | 2020  | 146  | 0.590  | 
                  Why?
                 |  | Vitamin D Deficiency | 1  | 2020  | 183  | 0.590  | 
                  Why?
                 |  | Disinfectants | 1  | 2018  | 38  | 0.580  | 
                  Why?
                 |  | Boston | 6  | 2021  | 92  | 0.580  | 
                  Why?
                 |  | Bayes Theorem | 5  | 2024  | 407  | 0.580  | 
                  Why?
                 |  | Vitamin D | 2  | 2023  | 393  | 0.570  | 
                  Why?
                 |  | Middle Aged | 40  | 2025  | 33355  | 0.570  | 
                  Why?
                 |  | Waist Circumference | 4  | 2016  | 143  | 0.570  | 
                  Why?
                 |  | Estrogens | 1  | 2020  | 361  | 0.560  | 
                  Why?
                 |  | Skinfold Thickness | 2  | 2018  | 46  | 0.540  | 
                  Why?
                 |  | Non-alcoholic Fatty Liver Disease | 1  | 2020  | 278  | 0.540  | 
                  Why?
                 |  | Biomarkers | 5  | 2024  | 4172  | 0.540  | 
                  Why?
                 |  | Sequence Analysis, DNA | 1  | 2020  | 812  | 0.530  | 
                  Why?
                 |  | Weight Loss | 5  | 2022  | 770  | 0.520  | 
                  Why?
                 |  | Age Factors | 6  | 2020  | 3301  | 0.520  | 
                  Why?
                 |  | Absorptiometry, Photon | 3  | 2025  | 252  | 0.510  | 
                  Why?
                 |  | Puberty | 2  | 2014  | 146  | 0.500  | 
                  Why?
                 |  | Young Adult | 18  | 2021  | 13243  | 0.500  | 
                  Why?
                 |  | Gastrointestinal Tract | 2  | 2015  | 194  | 0.490  | 
                  Why?
                 |  | Rural Population | 3  | 2018  | 567  | 0.490  | 
                  Why?
                 |  | Singapore | 5  | 2013  | 22  | 0.480  | 
                  Why?
                 |  | Adolescent | 24  | 2022  | 21555  | 0.470  | 
                  Why?
                 |  | Infant Welfare | 1  | 2014  | 9  | 0.470  | 
                  Why?
                 |  | Asthma | 3  | 2022  | 2290  | 0.460  | 
                  Why?
                 |  | Brazil | 7  | 2016  | 167  | 0.460  | 
                  Why?
                 |  | Abdominal Fat | 1  | 2014  | 40  | 0.450  | 
                  Why?
                 |  | Leptin | 1  | 2016  | 233  | 0.450  | 
                  Why?
                 |  | Health Status | 3  | 2023  | 784  | 0.440  | 
                  Why?
                 |  | Adiponectin | 1  | 2016  | 241  | 0.440  | 
                  Why?
                 |  | Intra-Abdominal Fat | 2  | 2024  | 91  | 0.430  | 
                  Why?
                 |  | Baltimore | 2  | 2024  | 58  | 0.420  | 
                  Why?
                 |  | Metabolic Syndrome | 4  | 2021  | 354  | 0.420  | 
                  Why?
                 |  | Vitamins | 3  | 2024  | 176  | 0.420  | 
                  Why?
                 |  | Diabetes, Gestational | 2  | 2018  | 316  | 0.420  | 
                  Why?
                 |  | Chronic Disease | 1  | 2019  | 1790  | 0.420  | 
                  Why?
                 |  | Glucose | 2  | 2015  | 1018  | 0.410  | 
                  Why?
                 |  | Feeding Behavior | 2  | 2017  | 652  | 0.410  | 
                  Why?
                 |  | Inflammation | 1  | 2024  | 2837  | 0.410  | 
                  Why?
                 |  | Dyslipidemias | 1  | 2015  | 177  | 0.410  | 
                  Why?
                 |  | Multicenter Studies as Topic | 2  | 2024  | 308  | 0.410  | 
                  Why?
                 |  | Linear Models | 6  | 2018  | 851  | 0.400  | 
                  Why?
                 |  | Wrist | 1  | 2013  | 54  | 0.400  | 
                  Why?
                 |  | Parity | 1  | 2013  | 126  | 0.400  | 
                  Why?
                 |  | Anthropometry | 1  | 2013  | 214  | 0.400  | 
                  Why?
                 |  | Fetal Development | 1  | 2016  | 296  | 0.400  | 
                  Why?
                 |  | Social Class | 1  | 2015  | 277  | 0.400  | 
                  Why?
                 |  | Aged | 23  | 2025  | 23798  | 0.390  | 
                  Why?
                 |  | Time Factors | 9  | 2024  | 6817  | 0.390  | 
                  Why?
                 |  | Herpesvirus 4, Human | 5  | 1998  | 167  | 0.380  | 
                  Why?
                 |  | Fatty Liver | 1  | 2014  | 242  | 0.380  | 
                  Why?
                 |  | Soy Foods | 1  | 2011  | 5  | 0.380  | 
                  Why?
                 |  | Soybean Proteins | 1  | 2011  | 14  | 0.380  | 
                  Why?
                 |  | Isoflavones | 1  | 2011  | 26  | 0.380  | 
                  Why?
                 |  | Micronutrients | 2  | 2023  | 95  | 0.370  | 
                  Why?
                 |  | Liver | 1  | 2020  | 1940  | 0.370  | 
                  Why?
                 |  | Gestational Age | 3  | 2021  | 903  | 0.360  | 
                  Why?
                 |  | Environmental Pollutants | 2  | 2024  | 160  | 0.360  | 
                  Why?
                 |  | Social Determinants of Health | 1  | 2015  | 251  | 0.360  | 
                  Why?
                 |  | Butyrates | 2  | 2022  | 61  | 0.350  | 
                  Why?
                 |  | Obesity, Abdominal | 3  | 2016  | 48  | 0.350  | 
                  Why?
                 |  | Renal Dialysis | 2  | 2024  | 434  | 0.340  | 
                  Why?
                 |  | Bifidobacterium | 2  | 2021  | 21  | 0.330  | 
                  Why?
                 |  | Risk Assessment | 6  | 2024  | 3439  | 0.330  | 
                  Why?
                 |  | Probiotics | 2  | 2021  | 53  | 0.330  | 
                  Why?
                 |  | Intestinal Mucosa | 1  | 2015  | 621  | 0.320  | 
                  Why?
                 |  | Maternal Exposure | 2  | 2024  | 188  | 0.320  | 
                  Why?
                 |  | Child Health | 2  | 2023  | 157  | 0.320  | 
                  Why?
                 |  | Randomized Controlled Trials as Topic | 3  | 2024  | 1465  | 0.320  | 
                  Why?
                 |  | Emigrants and Immigrants | 1  | 2012  | 137  | 0.310  | 
                  Why?
                 |  | Protective Factors | 3  | 2019  | 94  | 0.300  | 
                  Why?
                 |  | Follow-Up Studies | 8  | 2018  | 5139  | 0.300  | 
                  Why?
                 |  | Papillomavirus Vaccines | 1  | 2012  | 243  | 0.300  | 
                  Why?
                 |  | Socioeconomic Factors | 7  | 2021  | 1286  | 0.290  | 
                  Why?
                 |  | Denmark | 2  | 2025  | 46  | 0.290  | 
                  Why?
                 |  | Beverages | 2  | 2023  | 70  | 0.290  | 
                  Why?
                 |  | Case-Control Studies | 7  | 2023  | 3546  | 0.290  | 
                  Why?
                 |  | Renal Insufficiency, Chronic | 2  | 2024  | 616  | 0.280  | 
                  Why?
                 |  | Women, Working | 2  | 2017  | 12  | 0.280  | 
                  Why?
                 |  | Papillomavirus Infections | 1  | 2012  | 331  | 0.280  | 
                  Why?
                 |  | Prevalence | 10  | 2024  | 2719  | 0.280  | 
                  Why?
                 |  | Logistic Models | 7  | 2023  | 2064  | 0.270  | 
                  Why?
                 |  | Quality of Life | 1  | 2019  | 2870  | 0.270  | 
                  Why?
                 |  | Autism Spectrum Disorder | 2  | 2024  | 400  | 0.270  | 
                  Why?
                 |  | Hodgkin Disease | 3  | 1998  | 139  | 0.260  | 
                  Why?
                 |  | Body Size | 2  | 2018  | 108  | 0.250  | 
                  Why?
                 |  | Sodium, Dietary | 3  | 2025  | 41  | 0.250  | 
                  Why?
                 |  | Incidence | 7  | 2022  | 2792  | 0.250  | 
                  Why?
                 |  | Interviews as Topic | 3  | 2015  | 767  | 0.240  | 
                  Why?
                 |  | Emergency Medical Services | 1  | 2012  | 548  | 0.240  | 
                  Why?
                 |  | Infant, Low Birth Weight | 2  | 2016  | 141  | 0.240  | 
                  Why?
                 |  | Quebec | 1  | 2025  | 11  | 0.240  | 
                  Why?
                 |  | City Planning | 2  | 2022  | 3  | 0.240  | 
                  Why?
                 |  | Blood Glucose | 5  | 2021  | 2183  | 0.230  | 
                  Why?
                 |  | Sleep | 2  | 2023  | 754  | 0.230  | 
                  Why?
                 |  | Pregnancy Complications | 3  | 2024  | 521  | 0.230  | 
                  Why?
                 |  | Cities | 2  | 2022  | 132  | 0.220  | 
                  Why?
                 |  | Pregnancy Trimester, First | 2  | 2024  | 142  | 0.220  | 
                  Why?
                 |  | Infectious Mononucleosis | 2  | 1998  | 10  | 0.220  | 
                  Why?
                 |  | Folic Acid | 3  | 2024  | 186  | 0.220  | 
                  Why?
                 |  | Bacteroides fragilis | 1  | 2024  | 13  | 0.220  | 
                  Why?
                 |  | Ohio | 2  | 2015  | 154  | 0.220  | 
                  Why?
                 |  | Diet, Vegetarian | 1  | 2024  | 8  | 0.220  | 
                  Why?
                 |  | Fecal Microbiota Transplantation | 1  | 2024  | 23  | 0.220  | 
                  Why?
                 |  | Chemokine CCL2 | 1  | 2024  | 117  | 0.220  | 
                  Why?
                 |  | Biometry | 1  | 2024  | 70  | 0.220  | 
                  Why?
                 |  | Homeostasis | 3  | 2016  | 622  | 0.210  | 
                  Why?
                 |  | Antibodies, Viral | 6  | 1991  | 623  | 0.210  | 
                  Why?
                 |  | Kynurenine | 1  | 2024  | 114  | 0.210  | 
                  Why?
                 |  | Oligosaccharides | 1  | 2024  | 61  | 0.210  | 
                  Why?
                 |  | Research Design | 2  | 2021  | 1116  | 0.210  | 
                  Why?
                 |  | Clostridiales | 1  | 2023  | 3  | 0.210  | 
                  Why?
                 |  | Vitamin A | 1  | 2023  | 58  | 0.210  | 
                  Why?
                 |  | Severity of Illness Index | 3  | 2020  | 2838  | 0.210  | 
                  Why?
                 |  | Mucus | 1  | 2024  | 79  | 0.210  | 
                  Why?
                 |  | Metals | 1  | 2024  | 136  | 0.210  | 
                  Why?
                 |  | Nutrition Assessment | 2  | 2015  | 90  | 0.210  | 
                  Why?
                 |  | Maternal Age | 1  | 2023  | 130  | 0.210  | 
                  Why?
                 |  | Health Knowledge, Attitudes, Practice | 1  | 2012  | 1332  | 0.200  | 
                  Why?
                 |  | Tryptophan | 1  | 2024  | 183  | 0.200  | 
                  Why?
                 |  | Aging | 2  | 2024  | 1866  | 0.200  | 
                  Why?
                 |  | Cannabidiol | 1  | 2024  | 119  | 0.200  | 
                  Why?
                 |  | Phthalic Acids | 1  | 2022  | 46  | 0.190  | 
                  Why?
                 |  | Dronabinol | 1  | 2024  | 230  | 0.190  | 
                  Why?
                 |  | District of Columbia | 3  | 2021  | 27  | 0.190  | 
                  Why?
                 |  | Epidemiologic Studies | 1  | 2022  | 73  | 0.190  | 
                  Why?
                 |  | Anti-Infective Agents | 1  | 2024  | 256  | 0.190  | 
                  Why?
                 |  | Obesity Management | 1  | 2021  | 8  | 0.190  | 
                  Why?
                 |  | Urban Health | 1  | 2022  | 92  | 0.190  | 
                  Why?
                 |  | Hepatitis C | 3  | 2000  | 263  | 0.190  | 
                  Why?
                 |  | Insulin-Like Growth Factor Binding Protein 3 | 1  | 2021  | 39  | 0.190  | 
                  Why?
                 |  | Pancreatic Neoplasms | 1  | 2010  | 943  | 0.180  | 
                  Why?
                 |  | HTLV-I Antibodies | 5  | 1992  | 6  | 0.180  | 
                  Why?
                 |  | Sodium | 2  | 2021  | 218  | 0.180  | 
                  Why?
                 |  | Regression Analysis | 3  | 2012  | 1029  | 0.180  | 
                  Why?
                 |  | Registries | 2  | 2024  | 2021  | 0.180  | 
                  Why?
                 |  | Permeability | 1  | 2022  | 162  | 0.180  | 
                  Why?
                 |  | Glycemic Index | 1  | 2021  | 26  | 0.180  | 
                  Why?
                 |  | Purines | 1  | 2022  | 176  | 0.180  | 
                  Why?
                 |  | Cardiovascular System | 1  | 2023  | 141  | 0.180  | 
                  Why?
                 |  | Clostridium perfringens | 1  | 2021  | 5  | 0.180  | 
                  Why?
                 |  | Clostridium | 1  | 2021  | 17  | 0.180  | 
                  Why?
                 |  | Oxides | 1  | 2021  | 45  | 0.180  | 
                  Why?
                 |  | Bacteroides | 1  | 2021  | 21  | 0.180  | 
                  Why?
                 |  | Observational Studies as Topic | 1  | 2021  | 116  | 0.180  | 
                  Why?
                 |  | Sex Characteristics | 2  | 2016  | 766  | 0.180  | 
                  Why?
                 |  | Growth | 1  | 2021  | 61  | 0.180  | 
                  Why?
                 |  | Smoking | 4  | 2013  | 1639  | 0.170  | 
                  Why?
                 |  | Odds Ratio | 6  | 2023  | 1063  | 0.170  | 
                  Why?
                 |  | Glomerular Filtration Rate | 1  | 2024  | 746  | 0.170  | 
                  Why?
                 |  | Minority Groups | 1  | 2022  | 269  | 0.170  | 
                  Why?
                 |  | Uric Acid | 1  | 2021  | 164  | 0.170  | 
                  Why?
                 |  | Models, Statistical | 1  | 2024  | 667  | 0.170  | 
                  Why?
                 |  | Postpartum Period | 1  | 2023  | 341  | 0.170  | 
                  Why?
                 |  | Skin Absorption | 1  | 2019  | 12  | 0.160  | 
                  Why?
                 |  | Massachusetts | 1  | 2020  | 171  | 0.160  | 
                  Why?
                 |  | DNA, Ribosomal | 1  | 2020  | 86  | 0.160  | 
                  Why?
                 |  | Dysbiosis | 1  | 2021  | 180  | 0.160  | 
                  Why?
                 |  | Vulnerable Populations | 1  | 2021  | 163  | 0.160  | 
                  Why?
                 |  | Interdisciplinary Research | 1  | 2020  | 27  | 0.160  | 
                  Why?
                 |  | Appetite | 1  | 2020  | 68  | 0.160  | 
                  Why?
                 |  | Digestive System | 1  | 2019  | 28  | 0.160  | 
                  Why?
                 |  | Sex Factors | 4  | 2019  | 2074  | 0.160  | 
                  Why?
                 |  | Cost of Illness | 1  | 2022  | 304  | 0.160  | 
                  Why?
                 |  | Mercury | 1  | 2019  | 41  | 0.160  | 
                  Why?
                 |  | Cholesterol, HDL | 1  | 2020  | 205  | 0.160  | 
                  Why?
                 |  | Tumor Necrosis Factor-alpha | 1  | 2024  | 1242  | 0.160  | 
                  Why?
                 |  | Insulin-Like Growth Factor I | 1  | 2021  | 316  | 0.160  | 
                  Why?
                 |  | Cadmium | 1  | 2019  | 70  | 0.150  | 
                  Why?
                 |  | Lead | 1  | 2019  | 63  | 0.150  | 
                  Why?
                 |  | Venezuela | 1  | 2018  | 8  | 0.150  | 
                  Why?
                 |  | Men's Health | 1  | 2018  | 8  | 0.150  | 
                  Why?
                 |  | United States | 8  | 2023  | 14696  | 0.150  | 
                  Why?
                 |  | Employment | 2  | 2017  | 177  | 0.150  | 
                  Why?
                 |  | Behavior Therapy | 1  | 2021  | 262  | 0.150  | 
                  Why?
                 |  | United States Food and Drug Administration | 1  | 2019  | 208  | 0.150  | 
                  Why?
                 |  | Age Distribution | 2  | 2018  | 391  | 0.150  | 
                  Why?
                 |  | DNA, Bacterial | 1  | 2020  | 336  | 0.150  | 
                  Why?
                 |  | Kidney Failure, Chronic | 1  | 2024  | 565  | 0.150  | 
                  Why?
                 |  | Dizziness | 1  | 2019  | 83  | 0.150  | 
                  Why?
                 |  | Nutritional Status | 2  | 2024  | 344  | 0.140  | 
                  Why?
                 |  | Skin | 1  | 2023  | 751  | 0.140  | 
                  Why?
                 |  | Age of Onset | 2  | 2016  | 522  | 0.140  | 
                  Why?
                 |  | Lipopolysaccharides | 1  | 2022  | 886  | 0.140  | 
                  Why?
                 |  | Cholesterol, LDL | 1  | 2020  | 366  | 0.140  | 
                  Why?
                 |  | Health Status Disparities | 1  | 2021  | 285  | 0.140  | 
                  Why?
                 |  | Nutrition Surveys | 2  | 2021  | 268  | 0.140  | 
                  Why?
                 |  | Pregnancy Complications, Cardiovascular | 1  | 2018  | 81  | 0.140  | 
                  Why?
                 |  | Surveys and Questionnaires | 4  | 2014  | 5772  | 0.140  | 
                  Why?
                 |  | Infant, Small for Gestational Age | 1  | 2018  | 92  | 0.140  | 
                  Why?
                 |  | Reference Values | 1  | 2019  | 821  | 0.140  | 
                  Why?
                 |  | Public Health | 2  | 2021  | 579  | 0.140  | 
                  Why?
                 |  | Leukocytes | 1  | 2018  | 311  | 0.130  | 
                  Why?
                 |  | Verrucomicrobia | 1  | 2016  | 5  | 0.130  | 
                  Why?
                 |  | Japan | 6  | 2000  | 116  | 0.130  | 
                  Why?
                 |  | Computational Biology | 1  | 2021  | 645  | 0.130  | 
                  Why?
                 |  | Colombia | 2  | 2016  | 42  | 0.130  | 
                  Why?
                 |  | Clinical Trials as Topic | 2  | 2019  | 1047  | 0.130  | 
                  Why?
                 |  | Income | 1  | 2017  | 201  | 0.130  | 
                  Why?
                 |  | Confidence Intervals | 2  | 2012  | 328  | 0.130  | 
                  Why?
                 |  | Disease Progression | 1  | 2024  | 2755  | 0.130  | 
                  Why?
                 |  | Developing Countries | 2  | 2017  | 305  | 0.130  | 
                  Why?
                 |  | Death | 1  | 2017  | 119  | 0.130  | 
                  Why?
                 |  | Phylogeny | 1  | 2020  | 898  | 0.120  | 
                  Why?
                 |  | Aspartame | 1  | 2015  | 3  | 0.120  | 
                  Why?
                 |  | Liver Neoplasms | 2  | 2000  | 786  | 0.120  | 
                  Why?
                 |  | Preconception Care | 1  | 2016  | 43  | 0.120  | 
                  Why?
                 |  | Particulate Matter | 1  | 2018  | 314  | 0.120  | 
                  Why?
                 |  | Pandemics | 2  | 2021  | 1619  | 0.120  | 
                  Why?
                 |  | Intestines | 1  | 2018  | 359  | 0.120  | 
                  Why?
                 |  | Coffee | 1  | 2015  | 17  | 0.120  | 
                  Why?
                 |  | Epidemiologic Methods | 2  | 2013  | 96  | 0.120  | 
                  Why?
                 |  | Caffeine | 1  | 2015  | 68  | 0.120  | 
                  Why?
                 |  | Nutrition Policy | 1  | 2015  | 58  | 0.120  | 
                  Why?
                 |  | China | 1  | 2015  | 218  | 0.110  | 
                  Why?
                 |  | Animals | 7  | 2024  | 37011  | 0.110  | 
                  Why?
                 |  | Child Nutritional Physiological Phenomena | 1  | 2015  | 107  | 0.110  | 
                  Why?
                 |  | Elective Surgical Procedures | 1  | 2016  | 182  | 0.110  | 
                  Why?
                 |  | Body Weight | 1  | 2019  | 973  | 0.110  | 
                  Why?
                 |  | Dietary Supplements | 3  | 2024  | 563  | 0.110  | 
                  Why?
                 |  | Treatment Outcome | 4  | 2024  | 10821  | 0.110  | 
                  Why?
                 |  | Organ Size | 1  | 2015  | 479  | 0.110  | 
                  Why?
                 |  | Proportional Hazards Models | 2  | 2022  | 1263  | 0.110  | 
                  Why?
                 |  | California | 1  | 2015  | 425  | 0.110  | 
                  Why?
                 |  | Immunoglobulin M | 3  | 1991  | 288  | 0.100  | 
                  Why?
                 |  | Physical Examination | 1  | 2015  | 241  | 0.100  | 
                  Why?
                 |  | Multivariate Analysis | 3  | 2017  | 1524  | 0.100  | 
                  Why?
                 |  | Prognosis | 2  | 2019  | 4031  | 0.100  | 
                  Why?
                 |  | Analysis of Variance | 2  | 2015  | 1324  | 0.100  | 
                  Why?
                 |  | Glucose Metabolism Disorders | 1  | 2012  | 11  | 0.100  | 
                  Why?
                 |  | Oxidative Stress | 1  | 2019  | 1307  | 0.100  | 
                  Why?
                 |  | Diabetic Angiopathies | 1  | 2014  | 258  | 0.100  | 
                  Why?
                 |  | Central America | 1  | 2012  | 24  | 0.100  | 
                  Why?
                 |  | South America | 1  | 2012  | 59  | 0.090  | 
                  Why?
                 |  | Capsid Proteins | 2  | 1991  | 94  | 0.090  | 
                  Why?
                 |  | Abdomen | 1  | 2012  | 125  | 0.090  | 
                  Why?
                 |  | Area Under Curve | 1  | 2012  | 316  | 0.090  | 
                  Why?
                 |  | Brain | 1  | 2023  | 2831  | 0.090  | 
                  Why?
                 |  | Demography | 3  | 2017  | 292  | 0.090  | 
                  Why?
                 |  | Antigens, Viral | 3  | 1999  | 180  | 0.090  | 
                  Why?
                 |  | Lymphoma, Non-Hodgkin | 1  | 1991  | 88  | 0.090  | 
                  Why?
                 |  | ROC Curve | 1  | 2012  | 547  | 0.090  | 
                  Why?
                 |  | Immunoglobulin G | 3  | 1991  | 886  | 0.090  | 
                  Why?
                 |  | Carrier State | 3  | 1998  | 65  | 0.080  | 
                  Why?
                 |  | Cytokines | 1  | 2018  | 2095  | 0.080  | 
                  Why?
                 |  | Occupations | 3  | 2017  | 48  | 0.080  | 
                  Why?
                 |  | Dietary Sucrose | 1  | 2010  | 49  | 0.080  | 
                  Why?
                 |  | Diabetes Mellitus | 2  | 2016  | 1035  | 0.080  | 
                  Why?
                 |  | Uterine Cervical Neoplasms | 1  | 2012  | 255  | 0.080  | 
                  Why?
                 |  | Health Promotion | 1  | 2015  | 744  | 0.070  | 
                  Why?
                 |  | Mice | 2  | 2024  | 17843  | 0.070  | 
                  Why?
                 |  | Epidemiology | 1  | 2008  | 33  | 0.070  | 
                  Why?
                 |  | Predictive Value of Tests | 1  | 2013  | 2039  | 0.070  | 
                  Why?
                 |  | India | 2  | 2021  | 193  | 0.070  | 
                  Why?
                 |  | Hypoglycemic Agents | 1  | 2016  | 1285  | 0.070  | 
                  Why?
                 |  | Patient Selection | 1  | 2011  | 691  | 0.070  | 
                  Why?
                 |  | Cytomegalovirus | 1  | 1988  | 160  | 0.070  | 
                  Why?
                 |  | Smoking Cessation | 1  | 2011  | 447  | 0.070  | 
                  Why?
                 |  | Testicular Neoplasms | 1  | 1988  | 110  | 0.060  | 
                  Why?
                 |  | Human T-lymphotropic virus 1 | 2  | 1999  | 28  | 0.060  | 
                  Why?
                 |  | Nucleoside-Triphosphatase | 1  | 2006  | 6  | 0.060  | 
                  Why?
                 |  | Flavivirus | 1  | 2006  | 18  | 0.060  | 
                  Why?
                 |  | RNA Helicases | 1  | 2006  | 30  | 0.060  | 
                  Why?
                 |  | Waist-Hip Ratio | 2  | 2016  | 38  | 0.060  | 
                  Why?
                 |  | Viral Nonstructural Proteins | 1  | 2006  | 65  | 0.060  | 
                  Why?
                 |  | Muscle, Skeletal | 1  | 2015  | 1701  | 0.060  | 
                  Why?
                 |  | Lipids | 2  | 2022  | 664  | 0.060  | 
                  Why?
                 |  | Binomial Distribution | 1  | 2024  | 5  | 0.060  | 
                  Why?
                 |  | Spatial Analysis | 1  | 2024  | 21  | 0.060  | 
                  Why?
                 |  | Tomography, X-Ray Computed | 1  | 2014  | 2681  | 0.060  | 
                  Why?
                 |  | Georgia | 1  | 2024  | 84  | 0.060  | 
                  Why?
                 |  | Germany | 1  | 2024  | 121  | 0.060  | 
                  Why?
                 |  | Health Services Accessibility | 1  | 2012  | 976  | 0.060  | 
                  Why?
                 |  | Insulin | 3  | 2021  | 2398  | 0.050  | 
                  Why?
                 |  | Appointments and Schedules | 1  | 2024  | 89  | 0.050  | 
                  Why?
                 |  | Retrospective Studies | 3  | 2018  | 15628  | 0.050  | 
                  Why?
                 |  | Cross-Over Studies | 1  | 2025  | 561  | 0.050  | 
                  Why?
                 |  | Vegetables | 1  | 2023  | 155  | 0.050  | 
                  Why?
                 |  | Hospitalization | 2  | 2024  | 2197  | 0.050  | 
                  Why?
                 |  | Heartburn | 1  | 2021  | 12  | 0.050  | 
                  Why?
                 |  | Maryland | 1  | 2021  | 55  | 0.050  | 
                  Why?
                 |  | Nutritional Requirements | 1  | 2021  | 77  | 0.050  | 
                  Why?
                 |  | American Heart Association | 1  | 2023  | 306  | 0.040  | 
                  Why?
                 |  | Hunger | 1  | 2021  | 44  | 0.040  | 
                  Why?
                 |  | Gout | 1  | 2021  | 36  | 0.040  | 
                  Why?
                 |  | Iron | 1  | 2023  | 313  | 0.040  | 
                  Why?
                 |  | Africa, Eastern | 1  | 2020  | 12  | 0.040  | 
                  Why?
                 |  | Leukemia-Lymphoma, Adult T-Cell | 2  | 1991  | 14  | 0.040  | 
                  Why?
                 |  | Transportation | 1  | 2020  | 53  | 0.040  | 
                  Why?
                 |  | Causality | 1  | 2020  | 127  | 0.040  | 
                  Why?
                 |  | Capital Financing | 1  | 2020  | 7  | 0.040  | 
                  Why?
                 |  | Child Development | 1  | 2024  | 474  | 0.040  | 
                  Why?
                 |  | Tuberculin | 1  | 1999  | 8  | 0.040  | 
                  Why?
                 |  | Hepacivirus | 2  | 1998  | 258  | 0.040  | 
                  Why?
                 |  | Lipoproteins, HDL | 1  | 2019  | 77  | 0.040  | 
                  Why?
                 |  | Personal Satisfaction | 1  | 2021  | 211  | 0.040  | 
                  Why?
                 |  | Double-Blind Method | 1  | 2024  | 1987  | 0.040  | 
                  Why?
                 |  | Lipoproteins, LDL | 1  | 2019  | 119  | 0.040  | 
                  Why?
                 |  | Meconium | 1  | 2018  | 7  | 0.040  | 
                  Why?
                 |  | Viral Matrix Proteins | 1  | 1998  | 30  | 0.040  | 
                  Why?
                 |  | Oncogene Proteins, Viral | 1  | 1998  | 23  | 0.040  | 
                  Why?
                 |  | Th1 Cells | 1  | 1999  | 143  | 0.040  | 
                  Why?
                 |  | Mentoring | 1  | 2021  | 144  | 0.040  | 
                  Why?
                 |  | Aged, 80 and over | 5  | 1997  | 7593  | 0.040  | 
                  Why?
                 |  | Diet, Western | 1  | 2019  | 81  | 0.040  | 
                  Why?
                 |  | Virus Latency | 1  | 1998  | 85  | 0.040  | 
                  Why?
                 |  | Environmental Exposure | 1  | 2022  | 575  | 0.040  | 
                  Why?
                 |  | Pregnancy Trimester, Third | 1  | 2018  | 113  | 0.040  | 
                  Why?
                 |  | Metabolic Diseases | 1  | 2018  | 108  | 0.030  | 
                  Why?
                 |  | Cholesterol | 1  | 2019  | 413  | 0.030  | 
                  Why?
                 |  | Sex Distribution | 2  | 2014  | 378  | 0.030  | 
                  Why?
                 |  | Calcium | 1  | 2023  | 1233  | 0.030  | 
                  Why?
                 |  | Immunologic Memory | 1  | 1999  | 369  | 0.030  | 
                  Why?
                 |  | Triglycerides | 1  | 2019  | 525  | 0.030  | 
                  Why?
                 |  | Cancer Survivors | 1  | 2021  | 280  | 0.030  | 
                  Why?
                 |  | Sarcoma, Kaposi | 1  | 1997  | 78  | 0.030  | 
                  Why?
                 |  | Mucins | 1  | 2016  | 74  | 0.030  | 
                  Why?
                 |  | Deltaretrovirus Antibodies | 1  | 1996  | 1  | 0.030  | 
                  Why?
                 |  | Health Care Costs | 1  | 2019  | 387  | 0.030  | 
                  Why?
                 |  | Nutritional Physiological Phenomena | 1  | 2016  | 54  | 0.030  | 
                  Why?
                 |  | Viral Proteins | 1  | 1998  | 346  | 0.030  | 
                  Why?
                 |  | Health Behavior | 1  | 2021  | 764  | 0.030  | 
                  Why?
                 |  | Pregnancy Outcome | 1  | 2018  | 413  | 0.030  | 
                  Why?
                 |  | Health Surveys | 1  | 2017  | 520  | 0.030  | 
                  Why?
                 |  | Disease Transmission, Infectious | 1  | 1996  | 61  | 0.030  | 
                  Why?
                 |  | Environmental Monitoring | 1  | 2018  | 371  | 0.030  | 
                  Why?
                 |  | Databases, Factual | 1  | 2021  | 1351  | 0.030  | 
                  Why?
                 |  | Dominican Republic | 1  | 2015  | 24  | 0.030  | 
                  Why?
                 |  | Ambulatory Care | 1  | 2019  | 539  | 0.030  | 
                  Why?
                 |  | Educational Status | 1  | 2017  | 483  | 0.030  | 
                  Why?
                 |  | RNA, Viral | 1  | 1998  | 653  | 0.030  | 
                  Why?
                 |  | New York | 1  | 2015  | 133  | 0.030  | 
                  Why?
                 |  | Gene Products, tax | 2  | 1991  | 13  | 0.030  | 
                  Why?
                 |  | Body Fat Distribution | 1  | 2014  | 49  | 0.030  | 
                  Why?
                 |  | Hyperlipidemias | 1  | 2015  | 120  | 0.030  | 
                  Why?
                 |  | Hepatitis B | 1  | 1995  | 71  | 0.030  | 
                  Why?
                 |  | Glucose Tolerance Test | 1  | 2015  | 361  | 0.030  | 
                  Why?
                 |  | Communication | 1  | 2020  | 874  | 0.030  | 
                  Why?
                 |  | Poverty | 1  | 2017  | 520  | 0.030  | 
                  Why?
                 |  | HTLV-I Antigens | 2  | 1991  | 2  | 0.030  | 
                  Why?
                 |  | Epstein-Barr Virus Nuclear Antigens | 2  | 1991  | 10  | 0.030  | 
                  Why?
                 |  | Colorado | 1  | 2023  | 4521  | 0.020  | 
                  Why?
                 |  | HIV Seroprevalence | 1  | 1992  | 4  | 0.020  | 
                  Why?
                 |  | Sensitivity and Specificity | 1  | 2017  | 1950  | 0.020  | 
                  Why?
                 |  | Serologic Tests | 1  | 1992  | 54  | 0.020  | 
                  Why?
                 |  | Forestry | 1  | 1992  | 4  | 0.020  | 
                  Why?
                 |  | Fisheries | 1  | 1992  | 3  | 0.020  | 
                  Why?
                 |  | Leukemia, T-Cell | 1  | 1991  | 4  | 0.020  | 
                  Why?
                 |  | Toxoplasmosis | 1  | 1992  | 39  | 0.020  | 
                  Why?
                 |  | DNA | 1  | 2018  | 1460  | 0.020  | 
                  Why?
                 |  | Carcinoma, Hepatocellular | 1  | 1995  | 360  | 0.020  | 
                  Why?
                 |  | Hyperglycemia | 1  | 2015  | 346  | 0.020  | 
                  Why?
                 |  | Nasopharyngeal Neoplasms | 1  | 1991  | 21  | 0.020  | 
                  Why?
                 |  | Paraparesis, Tropical Spastic | 1  | 1991  | 3  | 0.020  | 
                  Why?
                 |  | Capsid | 1  | 1991  | 93  | 0.020  | 
                  Why?
                 |  | Agriculture | 1  | 1992  | 102  | 0.020  | 
                  Why?
                 |  | Reproducibility of Results | 1  | 2018  | 3292  | 0.020  | 
                  Why?
                 |  | Sexually Transmitted Diseases | 1  | 1991  | 158  | 0.020  | 
                  Why?
                 |  | Dysgerminoma | 1  | 1988  | 6  | 0.020  | 
                  Why?
                 |  | Sexual Behavior | 1  | 1992  | 487  | 0.020  | 
                  Why?
                 |  | Immunoglobulin A | 1  | 1989  | 210  | 0.020  | 
                  Why?
                 |  | Science | 1  | 2008  | 54  | 0.020  | 
                  Why?
                 |  | United Kingdom | 1  | 2008  | 324  | 0.020  | 
                  Why?
                 |  | Teratoma | 1  | 1988  | 114  | 0.020  | 
                  Why?
                 |  | History, 20th Century | 1  | 2008  | 324  | 0.020  | 
                  Why?
                 |  | Neoplasms | 1  | 2021  | 2666  | 0.020  | 
                  Why?
                 |  | Risk | 1  | 1989  | 905  | 0.020  | 
                  Why?
                 |  | HIV-1 | 1  | 1992  | 863  | 0.020  | 
                  Why?
                 |  | Phenotype | 1  | 2014  | 3205  | 0.020  | 
                  Why?
                 |  | Molecular Sequence Data | 2  | 2006  | 2901  | 0.020  | 
                  Why?
                 |  | Health Personnel | 1  | 1992  | 699  | 0.010  | 
                  Why?
                 |  | Sequence Homology, Amino Acid | 1  | 2006  | 387  | 0.010  | 
                  Why?
                 |  | Virus Replication | 1  | 1987  | 480  | 0.010  | 
                  Why?
                 |  | Recombinant Proteins | 2  | 1999  | 1357  | 0.010  | 
                  Why?
                 |  | Amino Acid Sequence | 1  | 2006  | 2146  | 0.010  | 
                  Why?
                 |  | Transcription Factors | 1  | 1989  | 1717  | 0.010  | 
                  Why?
                 |  | Tritium | 1  | 1999  | 76  | 0.010  | 
                  Why?
                 |  | Thymidine | 1  | 1999  | 60  | 0.010  | 
                  Why?
                 |  | Mycobacterium bovis | 1  | 1999  | 16  | 0.010  | 
                  Why?
                 |  | BCG Vaccine | 1  | 1999  | 24  | 0.010  | 
                  Why?
                 |  | Interleukin-12 | 1  | 1999  | 121  | 0.010  | 
                  Why?
                 |  | Erythema | 1  | 1998  | 29  | 0.010  | 
                  Why?
                 |  | Antigens, Bacterial | 1  | 1999  | 129  | 0.010  | 
                  Why?
                 |  | Blotting, Western | 2  | 1991  | 1227  | 0.010  | 
                  Why?
                 |  | Interleukin-2 | 1  | 1999  | 456  | 0.010  | 
                  Why?
                 |  | Cell Division | 1  | 1999  | 795  | 0.010  | 
                  Why?
                 |  | Greece | 1  | 1997  | 9  | 0.010  | 
                  Why?
                 |  | Interferon-gamma | 1  | 1999  | 790  | 0.010  | 
                  Why?
                 |  | Acquired Immunodeficiency Syndrome | 1  | 1997  | 233  | 0.010  | 
                  Why?
                 |  | Hepatitis Antibodies | 1  | 1995  | 1  | 0.010  | 
                  Why?
                 |  | Hepatitis B Surface Antigens | 1  | 1995  | 24  | 0.010  | 
                  Why?
                 |  | Otorhinolaryngologic Diseases | 1  | 1995  | 16  | 0.010  | 
                  Why?
                 |  | Hepatitis B virus | 1  | 1995  | 40  | 0.010  | 
                  Why?
                 |  | Seroepidemiologic Studies | 1  | 1995  | 163  | 0.010  | 
                  Why?
                 |  | Eye Diseases | 1  | 1995  | 87  | 0.010  | 
                  Why?
                 |  | Life Style | 1  | 1995  | 485  | 0.010  | 
                  Why?
                 |  | Homosexuality | 1  | 1992  | 18  | 0.010  | 
                  Why?
                 |  | Blood Transfusion | 1  | 1995  | 324  | 0.010  | 
                  Why?
                 |  | Retroviruses, Simian | 1  | 1991  | 1  | 0.010  | 
                  Why?
                 |  | Genes, pX | 1  | 1991  | 2  | 0.010  | 
                  Why?
                 |  | Bisexuality | 1  | 1992  | 31  | 0.010  | 
                  Why?
                 |  | Papio | 1  | 1991  | 93  | 0.010  | 
                  Why?
                 |  | Cells, Cultured | 1  | 1999  | 4206  | 0.010  | 
                  Why?
                 |  | Mexico | 1  | 1992  | 220  | 0.010  | 
                  Why?
                 |  | Agglutination Tests | 1  | 1991  | 4  | 0.010  | 
                  Why?
                 |  | Radioimmunoprecipitation Assay | 1  | 1990  | 6  | 0.010  | 
                  Why?
                 |  | Radioimmunoassay | 1  | 1991  | 174  | 0.010  | 
                  Why?
                 |  | DNA, Viral | 1  | 1991  | 362  | 0.000  | 
                  Why?
                 |  | Autoradiography | 1  | 1989  | 78  | 0.000  | 
                  Why?
                 |  | Precipitin Tests | 1  | 1989  | 100  | 0.000  | 
                  Why?
                 |  | Antibody Formation | 1  | 1991  | 299  | 0.000  | 
                  Why?
                 |  | Lymphocytes | 1  | 1991  | 395  | 0.000  | 
                  Why?
                 |  | Electrophoresis, Polyacrylamide Gel | 1  | 1989  | 346  | 0.000  | 
                  Why?
                 |  | Polymerase Chain Reaction | 1  | 1991  | 1061  | 0.000  | 
                  Why?
                 |  | Enzyme-Linked Immunosorbent Assay | 1  | 1990  | 849  | 0.000  | 
                  Why?
                 |  | Alcohol Drinking | 1  | 1995  | 824  | 0.000  | 
                  Why?
                 |  | Base Sequence | 1  | 1991  | 2180  | 0.000  | 
                  Why?
                 |  | Family | 1  | 1991  | 667  | 0.000  | 
                  Why?
                 |  | Trans-Activators | 1  | 1989  | 399  | 0.000  | 
                  Why?
                 |  | Postoperative Complications | 1  | 1995  | 2641  | 0.000  | 
                  Why?
                 |  
  
																				
                                                                            
																		
																	 
																 
															 | 
		
																
																	
																		
																			
																					
    Mueller's Networks
 
Click the "See All" links for more information and interactive visualizations!
 
																				
																					Concepts   Derived automatically from this person's publications. _ 
																				
																					Co-Authors   People in Profiles who have published with this person. _ 
																				
																					Similar People   People who share similar concepts with this person. _ 
																				
																					
        
            
                Same Department  
                     
                
             
            
				People who are also in this person's primary department.
			 
                 
        
    
																				
																					
																				
																		
																	 
																 
															 |